Wmg Financial Advisors, LLC Axsome Therapeutics, Inc. Transaction History

Wmg Financial Advisors, LLC

  • $206 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
SELL
$39.94 - $79.72 $199,700 - $398,600
-5,000 Reduced 33.67%
9,850 $759,000
Q2 2022

Aug 08, 2022
SELL
$21.74 - $46.75 $43,480 - $93,500
-2,000 Reduced 11.87%
14,850 $567,000
Q4 2021

Feb 14, 2022
BUY
$30.7 - $43.36 $517,295 - $730,616
16,850 New
16,850 $638,000

Others Institutions Holding AXSM

# of Institutions
325
Shares Held
37.7M
Call Options Held
912K
Put Options Held
855K
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.89B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Wmg Financial Advisors, LLC Portfolio

Follow Wmg Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wmg Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wmg Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email